SE8600998L - Parenterala fenytoinpreparat - Google Patents

Parenterala fenytoinpreparat

Info

Publication number
SE8600998L
SE8600998L SE8600998A SE8600998A SE8600998L SE 8600998 L SE8600998 L SE 8600998L SE 8600998 A SE8600998 A SE 8600998A SE 8600998 A SE8600998 A SE 8600998A SE 8600998 L SE8600998 L SE 8600998L
Authority
SE
Sweden
Prior art keywords
phenytoin
parenteral
preparation
preparations
sodium
Prior art date
Application number
SE8600998A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8600998D0 (sv
Inventor
M B Fawzi
A K Taylor
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SE8600998D0 publication Critical patent/SE8600998D0/xx
Publication of SE8600998L publication Critical patent/SE8600998L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8600998A 1985-05-20 1986-03-05 Parenterala fenytoinpreparat SE8600998L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/735,932 US4642316A (en) 1985-05-20 1985-05-20 Parenteral phenytoin preparations

Publications (2)

Publication Number Publication Date
SE8600998D0 SE8600998D0 (sv) 1986-03-05
SE8600998L true SE8600998L (sv) 1986-11-21

Family

ID=24957819

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8600998A SE8600998L (sv) 1985-05-20 1986-03-05 Parenterala fenytoinpreparat

Country Status (18)

Country Link
US (1) US4642316A (fr)
JP (1) JPS61268618A (fr)
AU (1) AU595790B2 (fr)
BE (1) BE904476A (fr)
CA (1) CA1268119A (fr)
CH (1) CH668594A5 (fr)
DE (1) DE3610330A1 (fr)
DK (1) DK100786A (fr)
ES (1) ES8707195A1 (fr)
FR (1) FR2581871B1 (fr)
GB (1) GB2175203B (fr)
IT (1) IT1190282B (fr)
LU (1) LU86383A1 (fr)
NL (1) NL8600899A (fr)
NZ (1) NZ215783A (fr)
PH (1) PH22922A (fr)
SE (1) SE8600998L (fr)
ZA (1) ZA862094B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3828156A1 (de) * 1988-08-19 1990-02-22 Astrapin Pharmazeutische Praep Stabile waessrige loesung von fluorouracil
AU8479998A (en) * 1997-07-22 1999-02-16 Warner-Lambert Company Lyophilized fosphenytoin sodium for parenteral use
US6245917B1 (en) 1998-03-20 2001-06-12 Warner-Lambert Company Crystalline sodium phenytoin monohydrate
US6274168B1 (en) 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions
AU2003288588A1 (en) * 2002-12-16 2004-07-09 Ranbaxy Laboratories Limited An extended release pharmaceutical composition of phenytoin sodium
EP1855760A2 (fr) 2005-02-03 2007-11-21 TopoTarget UK Limited Polytherapies faisant appel a des inhibiteurs de hdac
DE102005019393A1 (de) * 2005-04-25 2006-10-26 Basell Polyolefine Gmbh Polyethylenformmassen für Spritzgussanwendungen
AU2012213940B2 (en) * 2005-05-13 2015-03-26 Topotarget Uk Limited Pharmaceutical formulations of HDAC inhibitors
PL1901729T3 (pl) 2005-05-13 2012-07-31 Topotarget Uk Ltd Formulacje farmaceutyczne inhibitorów hdac
AU2006313517B2 (en) * 2005-11-10 2013-06-27 Topotarget Uk Limited Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent
WO2007067508A2 (fr) * 2005-12-05 2007-06-14 Taro Pharmaceuticals North America, Inc. Preparation pharmaceutique contenant de la phenytoine sodium et du stearate de magnesium
EP2203421B1 (fr) * 2007-09-25 2014-05-07 TopoTarget UK Limited Procédés de synthèse de certains composés n-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamides
MX2010009642A (es) * 2008-03-07 2010-09-22 Topotarget As Metodos de tratamiento utilizando infusion continua prolongada de belinostat.
GB0900555D0 (en) * 2009-01-14 2009-02-11 Topotarget As New methods
MX364974B (es) * 2009-05-19 2019-05-16 Neuroderm Ltd Composiciones para la administracion continua de inhibidores de dopa descarboxilasa.
WO2012066538A1 (fr) 2010-11-15 2012-05-24 Neuroderm Ltd Administration continue d'inhibiteurs de la l-dopa décarboxylase, d'inhibiteurs de la dopa décarboxylase, et d'inhibiteurs de la catéchol-o-méthyle transférase; et compositions correspondantes
US9540330B2 (en) 2010-12-15 2017-01-10 Nektar Therapeutics Oligomer-containing hydantoin compounds
EP3456315A1 (fr) 2012-06-05 2019-03-20 Neuroderm Ltd Compositions comprenant de l'apomorphine et acides organiques et leurs utilisations
RS65060B1 (sr) 2014-03-13 2024-02-29 Neuroderm Ltd Sastavi inhibitora dopa dekarboksilaze
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
WO2023205615A1 (fr) * 2022-04-18 2023-10-26 ISHA Therapeutics LLC Compositions de film antimicrobien à dissolution orale et leurs méthodes d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3749779A (en) * 1970-08-27 1973-07-31 American Home Prod Stable solutions of sodium diphenylhydantoin
JPS5221575B2 (fr) * 1972-03-18 1977-06-11
US4163058A (en) * 1977-04-22 1979-07-31 Interx Research Corporation Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof
US4260769A (en) * 1977-04-22 1981-04-07 Interx Research Corporation 5,5-Diphenylhydantoins

Also Published As

Publication number Publication date
GB8607383D0 (en) 1986-04-30
AU5441286A (en) 1986-11-27
FR2581871B1 (fr) 1990-05-11
DK100786A (da) 1986-11-21
CH668594A5 (fr) 1989-01-13
BE904476A (fr) 1986-09-24
DK100786D0 (da) 1986-03-05
PH22922A (en) 1989-01-24
IT1190282B (it) 1988-02-16
AU595790B2 (en) 1990-04-12
JPS61268618A (ja) 1986-11-28
IT8647936A0 (it) 1986-04-24
NZ215783A (en) 1989-01-27
ES8707195A1 (es) 1987-07-16
SE8600998D0 (sv) 1986-03-05
ES555143A0 (es) 1987-07-16
DE3610330A1 (de) 1986-11-20
GB2175203A (en) 1986-11-26
NL8600899A (nl) 1986-12-16
FR2581871A1 (fr) 1986-11-21
GB2175203B (en) 1988-09-14
CA1268119A (fr) 1990-04-24
ZA862094B (en) 1986-11-26
LU86383A1 (fr) 1986-09-02
US4642316A (en) 1987-02-10

Similar Documents

Publication Publication Date Title
SE8600998D0 (sv) Parenterala fenytoinpreparat
DK664187A (da) Hydrosolpraeparater
DK18088A (da) Taetningsarrangement
DE3766958D1 (de) Isochinolin-derivate.
DE3671372D1 (de) Etoposid-praeparate.
DK149988D0 (da) Stabile farmaceutiske praeparater
DK413987D0 (da) Farmaceutiske praeparater
SE8700203L (sv) Pyroglutamidderivat
DK133786D0 (da) Praeparater
DK111686A (da) Gelholdige farmaceutiske praeparater
DK401387D0 (da) Benzopyranderivatholdige praeparater
DK24986A (da) Allergenholdige praeparater
DK396986D0 (da) Parenterale phenytoin-praeparater
DK335587A (da) Vaeskefremmende veterinaerpraeparater
TR23272A (tr) Katlanan sedye
DK416386D0 (da) Dobbeltvirkende roereorgan
DK92287D0 (da) Drivstangsbeslag
IT208051Z2 (it) Cuscinetto con complesso di tenuta perfezionato
IT8721014A0 (it) 1-metansolfonilossi-6-trifluorometi l-1h-benzotriazolo e il suo impiego per preparare derivati della cefalosporina.
DK553487A (da) Baerbar projektoer
IT8648188A0 (it) Preparazioni di coloranti stabili
IT1206796B (it) 6-trifluorometil-1h-benzotriazol-1ile-difenilfosfato e il suo impiego per preparare derivati della cefaloscporina.
DK466086A (da) Exogent syrnede antacidiumpraeparater
AT386035B (de) Dichtung
KR870008562U (ko) 범용성 절첩식 골조 연결구

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8600998-2

Effective date: 19921001

Format of ref document f/p: F